MiR-548p decreases Hepatic Apolipoprotein B Secretion and Lipid Synthesis, acting at HBx/HNF4A/miR-548p/HBXIP pathway that controls hepatoma cell growth and tumorigenesis of hepatocellular carcinoma50. Here, LAMTOR5 is linked to hepatocellular carcinoma.